BCG helps biopharma companies fulfill their mission of delivering life-changing medicines and therapies, and take advantage of new technologies—including digital, data, and advanced analytics—in order to unlock innovation and bring new medicines to market faster.
Biopharma companies turn inspiration into innovation, discovering new medicines that improve and save lives—and they’re in the midst of transforming how they do it. The global pandemic has pushed digital, data, and analytics to the forefront of the industry, shortening the time it takes to develop new medicines and bring them to patients. Next-generation capabilities are driving more rapid and effective manufacturing and supply chains. They’re also enabling the swift redesign of networks, the creation of new commercial models and patient-engagement ventures, and the pursuit of new value-creation opportunities through M&A. BCG’s biopharma consulting experts work with companies to accelerate all of these changes, building a foundation for strong growth and sustained value creation.
We support clients in every aspect of biopharma excellence, including strategy, operations, and transformation. Increasingly, this means focusing on digital, data, and analytics, which are driving change throughout the biopharma value chain. BCG provides biopharma sector companies with custom solutions drawn from our deep knowledge of both digital and the industry. Our experts include an extensive group of PhDs and advanced-degree holders in biopharma industry-related disciplines with significant pre-consulting industry experience.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Our biopharma consultants work closely BCG’s specialty businesses on specific value-chain priorities, including digital supply chain, next-generation sales, personalization, and digital marketing. With our guidance, companies can rapidly scale new capabilities and ways of working through agile at scale, data and digital platforms, and our Build-Operate-Transferapproach. We collaborate with BCG GAMMA on projects that require applied data science and advanced analytics, and with BCG Digital Ventures to launch new businesses.
Jim Riley reveals how the company applied agile principles and frameworks within its highly regulated and structured environment, breaking down silos and significantly accelerating product delivery.
Jim Riley reveals how the company applied agile principles and frameworks within its highly regulated and structured environment, breaking down silos and significantly accelerating product delivery.
Discover what’s top of mind for health care CEOs and executives as they continue to navigate the challenges of the pandemic and imagine possibilities for the future.
IN SAVINGS
We guided a biopharma company through a multiyear transformation of its client network, production system, and supply model. The transformation included realigning site roles, combining portfolios, and pruning SKUs. It resulted in overall savings of more than $1.5 billion.
topLINE GROWTH INCREASE
At a major pharma company, topline growth for a previously underperforming product jumped 50% in a year after BCG used CRM, payer data, and other analytics to assess its promotional efforts and improve customer engagement.
มากกว่า 10 ปี ที่ MVP Consultant ให้บริการในการวิจัยตลาด การระบุเทรนด์ทางธุรกิจ ของแต่ละ Industry ตลอดจนการวางแผนกลยุทธ์ กำหนดกลยุทธ์ทางธุรกิจ การวางโครงสร้างธุรกิจ เพื่อสร้างการเปลี่ยนแปลง การเติบโต และขีดความสามารถทางการแข่งขันให้กับลูกค้าทั้งองค์การภาครัฐและเอกชน
We
are a strategic consulting firm that provides solutions based on the concept of
“We Hack, You Grow.” We utilize business insights, including data
analysis, critical issues assessment, market trends, and more, to design
strategies, business plans, and new S-curve business models for our clients.